"Calcitriol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
| Descriptor ID |
D002117
|
| MeSH Number(s) |
D04.210.500.247.222.159.478.387.300 D04.210.500.247.808.146.478.387.300 D04.210.500.812.768.196.478.387.300 D10.570.938.146.478.387.300
|
| Concept/Terms |
Calcitriol- Calcitriol
- 1 alpha,25-Dihydroxyvitamin D3
- 1 alpha,25 Dihydroxyvitamin D3
- D3, 1 alpha,25-Dihydroxyvitamin
- alpha,25-Dihydroxyvitamin D3, 1
- 1,25-Dihydroxyvitamin D3
- 1,25 Dihydroxyvitamin D3
- D3, 1,25-Dihydroxyvitamin
- 1 alpha,25-Dihydroxycholecalciferol
- 1 alpha,25 Dihydroxycholecalciferol
- 1,25-Dihydroxycholecalciferol
- 1,25 Dihydroxycholecalciferol
20-epi-1alpha,25-dihydroxycholecaliferol- 20-epi-1alpha,25-dihydroxycholecaliferol
- 20 epi 1alpha,25 dihydroxycholecaliferol
- 1,25-dihydroxy-20-epi-Vitamin D3
- 1,25 dihydroxy 20 epi Vitamin D3
- D3, 1,25-dihydroxy-20-epi-Vitamin
- 1,25(OH)2-20epi-D3
- 1 alpha, 25-dihydroxy-20-epi-Vitamin D3
- 1 alpha, 25 dihydroxy 20 epi Vitamin D3
|
Below are MeSH descriptors whose meaning is more general than "Calcitriol".
Below are MeSH descriptors whose meaning is more specific than "Calcitriol".
This graph shows the total number of publications written about "Calcitriol" by people in this website by year, and whether "Calcitriol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcitriol" by people in Profiles.
-
Hassoon A, Michos ED, Miller ER, Crisp Z, Appel LJ. Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial. Nutrients. 2018 Mar 17; 10(3).
-
Ng AH, Frick KK, Krieger NS, Asplin JR, Cohen-McFarlane M, Culbertson CD, Kyker-Snowman K, Grynpas MD, Bushinsky DA. 1,25(OH)2D3 induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats. Calcif Tissue Int. 2014 May; 94(5):531-43.
-
Grindel BJ, Rohe B, Safford SE, Bennett JJ, Farach-Carson MC. Tumor necrosis factor-a treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D3-MARRS to the nucleus. J Cell Biochem. 2011 Sep; 112(9):2606-15.
-
Dirks-Naylor AJ, Lennon-Edwards S. The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol. 2011 Jul; 125(3-5):159-68.
-
Damera G, Fogle HW, Lim P, Goncharova EA, Zhao H, Banerjee A, Tliba O, Krymskaya VP, Panettieri RA. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol. 2009 Nov; 158(6):1429-41.
-
Banerjee A, Damera G, Bhandare R, Gu S, Lopez-Boado Y, Panettieri R, Tliba O. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol. 2008 Sep; 155(1):84-92.
-
Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC. Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol. 2006 Mar; 290(3):C822-31.
-
Morris MJ, Smaletz O, Solit D, Kelly WK, Slovin S, Flombaum C, Curley T, Delacruz A, Schwartz L, Fleisher M, Zhu A, Diani M, Fallon M, Scher HI. High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma. Cancer. 2004 May 01; 100(9):1868-75.
-
Sakarcan A. Chronic interstitial nephritis in two siblings. J S C Med Assoc. 2003 Oct; 99(10):305-6.
-
Shabahang M, Buffan AE, Nolla JM, Schumaker LM, Brenner RV, Buras RR, Nauta RJ, Evans SR. The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor. Ann Surg Oncol. 1996 Mar; 3(2):144-9.